Effect of repeat catheter ablation vs. antiarrhythmic drug therapy among patients with recurrent atrial tachycardia/atrial fibrillation after atrial fibrillation catheter ablation: data from CHINA-AF registry.
Lu ZhouLiu HeWei WangChangyi LiSong-Nan LiRi-Bo TangCai-Hua SangNian LiuChenxi JiangRonghui YuDeyong LongXin DuChunguang QiuChangsheng MaPublished in: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology (2022)
Based on this research, in recurrent AT/AF patients after a catheter ablation procedure, compared with medical therapy, repeat catheter ablation may significantly reduce the risk of the endpoint of composite cardiovascular mortality, ischaemic stroke, and major bleeding events.
Keyphrases
- catheter ablation
- atrial fibrillation
- left atrial
- left atrial appendage
- oral anticoagulants
- direct oral anticoagulants
- end stage renal disease
- heart failure
- newly diagnosed
- percutaneous coronary intervention
- ejection fraction
- healthcare
- chronic kidney disease
- prognostic factors
- cardiovascular events
- peritoneal dialysis
- type diabetes
- electronic health record
- minimally invasive
- big data
- patient reported outcomes
- cell therapy
- machine learning
- coronary artery disease
- venous thromboembolism
- data analysis